Cumulative cancer length in selecting candidates for Active Surveillance: use or abuse?
Sir, Chen et al. [1] have performed an interesting evaluation on cumulative cancer length on prostate needle biopsy (Bx) divided by the number of biopsy cores (CCL/core) in predicting outcomes after radical prostatectomy (RP) in candidates for Active Surveillance (AS). Criticisms against AS criteria could concern the relevant proportion of upstaging, upgrading or unfavourable cancer […]